| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord | 114 | 2017 | 202 | 15.410 |
Why?
|
| Neurons | 66 | 2021 | 275 | 7.640 |
Why?
|
| Heart | 56 | 2019 | 219 | 5.940 |
Why?
|
| Neurons, Afferent | 48 | 2012 | 64 | 4.090 |
Why?
|
| Rats, Sprague-Dawley | 85 | 2020 | 545 | 3.960 |
Why?
|
| Afferent Pathways | 56 | 2020 | 62 | 3.830 |
Why?
|
| Rats | 96 | 2020 | 1545 | 3.790 |
Why?
|
| Electric Stimulation Therapy | 23 | 2020 | 56 | 3.590 |
Why?
|
| Pain | 38 | 2017 | 252 | 3.170 |
Why?
|
| Electric Stimulation | 82 | 2017 | 253 | 2.960 |
Why?
|
| Spinal Cord Stimulation | 9 | 2019 | 13 | 2.960 |
Why?
|
| Animals | 217 | 2024 | 9960 | 2.900 |
Why?
|
| Nociceptors | 18 | 2012 | 42 | 2.780 |
Why?
|
| Colon | 17 | 2019 | 119 | 2.620 |
Why?
|
| Action Potentials | 38 | 2018 | 194 | 2.540 |
Why?
|
| Urinary Bladder | 19 | 2012 | 118 | 2.320 |
Why?
|
| Angina Pectoris | 15 | 2015 | 109 | 2.260 |
Why?
|
| Spinothalamic Tracts | 35 | 2010 | 35 | 2.180 |
Why?
|
| Spinal Nerves | 11 | 2020 | 13 | 2.120 |
Why?
|
| Skin | 23 | 2013 | 140 | 2.040 |
Why?
|
| Vasodilation | 13 | 2013 | 114 | 1.990 |
Why?
|
| Esophagus | 11 | 2010 | 69 | 1.920 |
Why?
|
| Stomach | 8 | 2020 | 42 | 1.890 |
Why?
|
| Male | 120 | 2020 | 12869 | 1.880 |
Why?
|
| Neural Inhibition | 31 | 2012 | 47 | 1.870 |
Why?
|
| Physical Stimulation | 33 | 2017 | 70 | 1.870 |
Why?
|
| Vagus Nerve | 35 | 2020 | 106 | 1.830 |
Why?
|
| Autonomic Nervous System | 16 | 2020 | 110 | 1.550 |
Why?
|
| Visceral Afferents | 10 | 2012 | 12 | 1.480 |
Why?
|
| Sympathetic Nervous System | 30 | 2008 | 64 | 1.420 |
Why?
|
| Posterior Horn Cells | 6 | 2018 | 10 | 1.410 |
Why?
|
| Rectum | 10 | 2015 | 50 | 1.400 |
Why?
|
| TRPV Cation Channels | 8 | 2024 | 15 | 1.390 |
Why?
|
| Pericardium | 9 | 2010 | 47 | 1.310 |
Why?
|
| Pain Management | 8 | 2017 | 52 | 1.290 |
Why?
|
| Bradykinin | 24 | 2010 | 27 | 1.290 |
Why?
|
| Ischemia | 5 | 2019 | 83 | 1.270 |
Why?
|
| Myocardial Ischemia | 12 | 2012 | 73 | 1.250 |
Why?
|
| Spinal Cord Injuries | 11 | 2014 | 55 | 1.060 |
Why?
|
| Electroacupuncture | 7 | 2020 | 7 | 1.050 |
Why?
|
| Reflex | 13 | 2020 | 74 | 1.030 |
Why?
|
| Models, Animal | 2 | 2018 | 129 | 1.020 |
Why?
|
| Pain Measurement | 3 | 2017 | 159 | 1.000 |
Why?
|
| Sensory Receptor Cells | 5 | 2010 | 14 | 0.900 |
Why?
|
| Blood Pressure | 25 | 2009 | 351 | 0.900 |
Why?
|
| Macaca fascicularis | 35 | 2002 | 45 | 0.880 |
Why?
|
| Colitis | 7 | 2019 | 53 | 0.860 |
Why?
|
| Neural Pathways | 12 | 2012 | 118 | 0.860 |
Why?
|
| Heart Conduction System | 8 | 2011 | 270 | 0.830 |
Why?
|
| Heart Rate | 30 | 2017 | 374 | 0.820 |
Why?
|
| Thalamus | 13 | 1992 | 26 | 0.810 |
Why?
|
| Nociception | 2 | 2015 | 51 | 0.810 |
Why?
|
| Nerve Fibers | 12 | 2007 | 53 | 0.800 |
Why?
|
| Thorax | 14 | 2008 | 28 | 0.790 |
Why?
|
| Disease Models, Animal | 19 | 2019 | 1393 | 0.780 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2020 | 13 | 0.760 |
Why?
|
| Lung | 17 | 2007 | 349 | 0.760 |
Why?
|
| Lumbosacral Plexus | 4 | 2020 | 7 | 0.730 |
Why?
|
| Amygdala | 5 | 2008 | 52 | 0.730 |
Why?
|
| Laser-Doppler Flowmetry | 9 | 2013 | 16 | 0.720 |
Why?
|
| Gastrointestinal Motility | 8 | 2018 | 30 | 0.720 |
Why?
|
| Phrenic Nerve | 9 | 2004 | 22 | 0.690 |
Why?
|
| Cervical Vertebrae | 15 | 2012 | 112 | 0.650 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2011 | 96 | 0.650 |
Why?
|
| Electrophysiology | 20 | 2007 | 150 | 0.640 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 9 | 0.630 |
Why?
|
| Dyspepsia | 4 | 2020 | 10 | 0.620 |
Why?
|
| Diterpenes | 5 | 2012 | 19 | 0.610 |
Why?
|
| Synaptic Transmission | 8 | 2019 | 48 | 0.590 |
Why?
|
| Thoracic Vertebrae | 9 | 2011 | 66 | 0.580 |
Why?
|
| Duodenum | 2 | 2007 | 15 | 0.570 |
Why?
|
| Mechanoreceptors | 6 | 2010 | 10 | 0.560 |
Why?
|
| Blood Circulation | 2 | 2009 | 12 | 0.560 |
Why?
|
| Cats | 29 | 2009 | 47 | 0.540 |
Why?
|
| Capsaicin | 4 | 2010 | 18 | 0.540 |
Why?
|
| Ventricular Fibrillation | 13 | 2019 | 40 | 0.540 |
Why?
|
| Inflammation | 8 | 2024 | 601 | 0.520 |
Why?
|
| Posture | 2 | 2013 | 39 | 0.510 |
Why?
|
| Lumbar Vertebrae | 6 | 2009 | 123 | 0.510 |
Why?
|
| Temperature | 3 | 2013 | 207 | 0.490 |
Why?
|
| Regional Blood Flow | 7 | 2013 | 159 | 0.490 |
Why?
|
| Pressure | 6 | 2012 | 88 | 0.490 |
Why?
|
| Medulla Oblongata | 5 | 2010 | 12 | 0.490 |
Why?
|
| Corticosterone | 4 | 2003 | 33 | 0.490 |
Why?
|
| Dogs | 36 | 2019 | 504 | 0.480 |
Why?
|
| Myocardial Infarction | 17 | 2012 | 342 | 0.470 |
Why?
|
| Reticular Formation | 7 | 1990 | 7 | 0.470 |
Why?
|
| Stimulation, Chemical | 11 | 2011 | 32 | 0.470 |
Why?
|
| Viscera | 6 | 2007 | 18 | 0.460 |
Why?
|
| Gastric Emptying | 6 | 2020 | 8 | 0.460 |
Why?
|
| Algorithms | 1 | 2017 | 419 | 0.460 |
Why?
|
| Hindlimb | 11 | 2009 | 20 | 0.460 |
Why?
|
| Wavelet Analysis | 2 | 2013 | 10 | 0.440 |
Why?
|
| Aldosterone | 2 | 2003 | 4 | 0.440 |
Why?
|
| Lumbosacral Region | 10 | 2013 | 20 | 0.430 |
Why?
|
| Neuralgia | 4 | 2017 | 18 | 0.430 |
Why?
|
| Calcitonin Gene-Related Peptide | 5 | 2009 | 27 | 0.420 |
Why?
|
| Patient Positioning | 1 | 2013 | 22 | 0.420 |
Why?
|
| Nociceptive Pain | 1 | 2012 | 11 | 0.400 |
Why?
|
| Brain | 3 | 2015 | 699 | 0.390 |
Why?
|
| Sacrum | 3 | 2009 | 23 | 0.390 |
Why?
|
| Proestrus | 1 | 2011 | 1 | 0.390 |
Why?
|
| Cardiovascular System | 5 | 1998 | 39 | 0.380 |
Why?
|
| Chest Pain | 1 | 2011 | 25 | 0.380 |
Why?
|
| Neck | 8 | 2003 | 25 | 0.370 |
Why?
|
| Neurotransmitter Agents | 2 | 2009 | 20 | 0.370 |
Why?
|
| Efferent Pathways | 5 | 2020 | 6 | 0.370 |
Why?
|
| Dilatation | 2 | 2007 | 4 | 0.360 |
Why?
|
| Solitary Nucleus | 3 | 2020 | 15 | 0.350 |
Why?
|
| Sex Characteristics | 1 | 2011 | 162 | 0.350 |
Why?
|
| Vagotomy | 14 | 2007 | 21 | 0.350 |
Why?
|
| Cerebrovascular Circulation | 2 | 2009 | 211 | 0.350 |
Why?
|
| Electromyography | 6 | 2017 | 172 | 0.350 |
Why?
|
| Humans | 32 | 2024 | 26826 | 0.350 |
Why?
|
| Evoked Potentials | 23 | 2007 | 49 | 0.340 |
Why?
|
| Stellate Ganglion | 9 | 2019 | 21 | 0.340 |
Why?
|
| Thalamic Nuclei | 5 | 1998 | 5 | 0.340 |
Why?
|
| Body Weight | 3 | 2017 | 246 | 0.340 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 84 | 0.330 |
Why?
|
| Injections | 8 | 2010 | 31 | 0.330 |
Why?
|
| Adrenergic Fibers | 5 | 2003 | 8 | 0.320 |
Why?
|
| Stomach Diseases | 2 | 2020 | 4 | 0.320 |
Why?
|
| Chronic Pain | 3 | 2014 | 59 | 0.320 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 79 | 0.320 |
Why?
|
| Time Factors | 14 | 2017 | 1562 | 0.320 |
Why?
|
| Pain, Intractable | 1 | 2008 | 2 | 0.300 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 207 | 0.300 |
Why?
|
| Peptide Fragments | 4 | 2009 | 197 | 0.300 |
Why?
|
| Electrodes, Implanted | 7 | 2018 | 40 | 0.300 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 44 | 0.300 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2008 | 4 | 0.300 |
Why?
|
| Constipation | 2 | 2019 | 21 | 0.290 |
Why?
|
| Death, Sudden, Cardiac | 5 | 2012 | 28 | 0.280 |
Why?
|
| Pelvic Pain | 1 | 2007 | 10 | 0.280 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2018 | 65 | 0.280 |
Why?
|
| Vascular Resistance | 3 | 2008 | 50 | 0.280 |
Why?
|
| Central Nervous System | 4 | 2020 | 36 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 147 | 0.280 |
Why?
|
| Stress, Psychological | 2 | 2020 | 209 | 0.270 |
Why?
|
| Interneurons | 3 | 2004 | 24 | 0.270 |
Why?
|
| Heart Diseases | 1 | 2007 | 68 | 0.270 |
Why?
|
| Stress, Mechanical | 4 | 2024 | 102 | 0.260 |
Why?
|
| Cerebellar Nuclei | 7 | 1989 | 8 | 0.260 |
Why?
|
| Norepinephrine | 3 | 2020 | 32 | 0.260 |
Why?
|
| Catheterization | 5 | 2008 | 50 | 0.250 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 2 | 1996 | 25 | 0.250 |
Why?
|
| Ganglia, Spinal | 9 | 2007 | 25 | 0.240 |
Why?
|
| Nerve Fibers, Myelinated | 5 | 2003 | 22 | 0.240 |
Why?
|
| Raphe Nuclei | 3 | 1994 | 3 | 0.240 |
Why?
|
| Ileus | 2 | 2018 | 7 | 0.240 |
Why?
|
| Splanchnic Nerves | 8 | 2000 | 8 | 0.240 |
Why?
|
| Signal Transduction | 2 | 2008 | 1344 | 0.230 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2024 | 23 | 0.230 |
Why?
|
| Denervation | 5 | 2012 | 10 | 0.230 |
Why?
|
| Sensory Thresholds | 3 | 2018 | 13 | 0.230 |
Why?
|
| Laminectomy | 4 | 2012 | 30 | 0.230 |
Why?
|
| Gastrointestinal Diseases | 2 | 2015 | 54 | 0.220 |
Why?
|
| Female | 23 | 2019 | 14462 | 0.220 |
Why?
|
| Respiratory System | 2 | 2004 | 13 | 0.220 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 623 | 0.220 |
Why?
|
| Reflex, Abdominal | 1 | 2003 | 1 | 0.220 |
Why?
|
| Calcium | 1 | 2024 | 231 | 0.210 |
Why?
|
| Endothelial Cells | 2 | 2024 | 324 | 0.210 |
Why?
|
| Glutamic Acid | 5 | 2004 | 50 | 0.210 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2003 | 4 | 0.210 |
Why?
|
| Cold Temperature | 1 | 2003 | 34 | 0.210 |
Why?
|
| Nerve Net | 1 | 2004 | 105 | 0.210 |
Why?
|
| Coronary Circulation | 2 | 2007 | 30 | 0.210 |
Why?
|
| Heart Atria | 3 | 2002 | 171 | 0.210 |
Why?
|
| Acupuncture Points | 3 | 2019 | 3 | 0.200 |
Why?
|
| Blood Flow Velocity | 2 | 2007 | 63 | 0.200 |
Why?
|
| Intestine, Small | 3 | 2015 | 66 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 243 | 0.200 |
Why?
|
| Rats, Inbred F344 | 6 | 2008 | 167 | 0.200 |
Why?
|
| Gastroparesis | 2 | 2020 | 4 | 0.200 |
Why?
|
| Ganglia, Autonomic | 2 | 2002 | 55 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2003 | 110 | 0.200 |
Why?
|
| Movement | 2 | 2001 | 92 | 0.200 |
Why?
|
| Transcriptome | 2 | 2021 | 198 | 0.190 |
Why?
|
| Trinitrobenzenesulfonic Acid | 5 | 2017 | 14 | 0.190 |
Why?
|
| Blood Glucose | 2 | 2015 | 300 | 0.190 |
Why?
|
| Iodoacetamide | 2 | 2020 | 2 | 0.190 |
Why?
|
| Gastrointestinal Transit | 2 | 2019 | 8 | 0.190 |
Why?
|
| Death, Sudden | 5 | 1995 | 15 | 0.190 |
Why?
|
| Microelectrodes | 5 | 2009 | 18 | 0.180 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 21 | 0.180 |
Why?
|
| Functional Laterality | 6 | 2008 | 62 | 0.180 |
Why?
|
| Sympathectomy | 2 | 2019 | 16 | 0.180 |
Why?
|
| Obesity | 2 | 2017 | 650 | 0.180 |
Why?
|
| Neural Conduction | 12 | 2003 | 24 | 0.180 |
Why?
|
| Analysis of Variance | 4 | 2017 | 388 | 0.180 |
Why?
|
| Eating | 2 | 2017 | 66 | 0.170 |
Why?
|
| Nitrergic Neurons | 1 | 2020 | 1 | 0.170 |
Why?
|
| Somatosensory Disorders | 1 | 2000 | 1 | 0.170 |
Why?
|
| Chromatin | 1 | 2020 | 74 | 0.170 |
Why?
|
| Proprioception | 2 | 1998 | 5 | 0.170 |
Why?
|
| NF-kappa B | 1 | 2020 | 187 | 0.170 |
Why?
|
| Biophysics | 2 | 2017 | 14 | 0.170 |
Why?
|
| Skin Physiological Phenomena | 2 | 2009 | 8 | 0.170 |
Why?
|
| Evoked Potentials, Somatosensory | 3 | 1996 | 12 | 0.170 |
Why?
|
| Recovery of Function | 2 | 2018 | 111 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2019 | 163 | 0.170 |
Why?
|
| Trigeminal Nerve | 1 | 1999 | 5 | 0.170 |
Why?
|
| Coronary Disease | 6 | 2004 | 118 | 0.160 |
Why?
|
| Neurites | 1 | 1999 | 9 | 0.160 |
Why?
|
| Hexamethonium | 3 | 2004 | 3 | 0.160 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 439 | 0.160 |
Why?
|
| Macaca | 5 | 1989 | 19 | 0.160 |
Why?
|
| Sciatic Nerve | 1 | 2018 | 2 | 0.160 |
Why?
|
| Stilbamidines | 1 | 1998 | 1 | 0.160 |
Why?
|
| Prone Position | 2 | 2013 | 5 | 0.160 |
Why?
|
| Cardiovascular Physiological Phenomena | 5 | 2002 | 22 | 0.150 |
Why?
|
| Urinary Bladder Diseases | 2 | 2012 | 9 | 0.150 |
Why?
|
| Mesencephalon | 2 | 1989 | 6 | 0.150 |
Why?
|
| Models, Neurological | 3 | 2015 | 31 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 5 | 2012 | 65 | 0.150 |
Why?
|
| Treatment Outcome | 3 | 2017 | 2264 | 0.150 |
Why?
|
| Paresthesia | 1 | 2017 | 1 | 0.140 |
Why?
|
| Pressoreceptors | 6 | 1993 | 8 | 0.140 |
Why?
|
| Acupuncture, Ear | 1 | 2017 | 2 | 0.140 |
Why?
|
| Extracellular Space | 4 | 2008 | 25 | 0.140 |
Why?
|
| Pons | 2 | 1987 | 7 | 0.140 |
Why?
|
| Microcirculation | 3 | 2013 | 111 | 0.140 |
Why?
|
| Acute Disease | 5 | 2007 | 153 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 1997 | 49 | 0.140 |
Why?
|
| Low Back Pain | 1 | 2017 | 28 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2008 | 586 | 0.140 |
Why?
|
| Reaction Time | 6 | 2006 | 94 | 0.140 |
Why?
|
| Foot | 2 | 2009 | 21 | 0.140 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 130 | 0.140 |
Why?
|
| Electrocardiography | 7 | 2017 | 391 | 0.120 |
Why?
|
| Intestinal Diseases | 1 | 2015 | 11 | 0.120 |
Why?
|
| Hot Temperature | 2 | 2013 | 84 | 0.120 |
Why?
|
| Heart Ventricles | 5 | 2019 | 127 | 0.120 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 5 | 0.120 |
Why?
|
| Rhizotomy | 3 | 2004 | 3 | 0.120 |
Why?
|
| Ammonia | 4 | 2007 | 18 | 0.120 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 46 | 0.120 |
Why?
|
| Back Pain | 1 | 2014 | 20 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2015 | 66 | 0.120 |
Why?
|
| Forelimb | 4 | 1998 | 6 | 0.120 |
Why?
|
| Muscle, Smooth | 3 | 2014 | 40 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 77 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 113 | 0.110 |
Why?
|
| Myocardial Contraction | 3 | 1988 | 60 | 0.110 |
Why?
|
| Muscles | 6 | 1992 | 70 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 144 | 0.110 |
Why?
|
| Visceral Pain | 1 | 2013 | 20 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 176 | 0.110 |
Why?
|
| Brucella abortus | 1 | 2013 | 3 | 0.110 |
Why?
|
| Brucellosis | 1 | 2013 | 6 | 0.110 |
Why?
|
| Diabetic Foot | 1 | 2013 | 17 | 0.110 |
Why?
|
| Mice | 5 | 2024 | 4406 | 0.110 |
Why?
|
| Analgesia, Epidural | 1 | 1993 | 4 | 0.110 |
Why?
|
| Coronary Stenosis | 2 | 2004 | 19 | 0.110 |
Why?
|
| Stereotaxic Techniques | 3 | 2003 | 14 | 0.110 |
Why?
|
| Skin Temperature | 1 | 2012 | 5 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 56 | 0.100 |
Why?
|
| Biguanides | 1 | 1992 | 1 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 100 | 0.100 |
Why?
|
| Ganglionic Blockers | 2 | 2003 | 3 | 0.100 |
Why?
|
| Cranial Nerves | 1 | 2012 | 6 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2017 | 247 | 0.100 |
Why?
|
| Surface Properties | 1 | 2012 | 132 | 0.100 |
Why?
|
| Drug Combinations | 2 | 2003 | 50 | 0.100 |
Why?
|
| Nodose Ganglion | 1 | 1991 | 1 | 0.100 |
Why?
|
| Pain, Referred | 1 | 2011 | 1 | 0.100 |
Why?
|
| Physical Exertion | 8 | 1998 | 98 | 0.100 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2012 | 64 | 0.090 |
Why?
|
| Cervical Plexus | 1 | 1991 | 3 | 0.090 |
Why?
|
| Intestines | 2 | 2017 | 117 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 503 | 0.090 |
Why?
|
| Wheelchairs | 1 | 2010 | 5 | 0.090 |
Why?
|
| Rhodamines | 1 | 2010 | 10 | 0.090 |
Why?
|
| Dextrans | 1 | 2010 | 22 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2013 | 700 | 0.090 |
Why?
|
| Brain Stem | 3 | 1986 | 22 | 0.090 |
Why?
|
| Caulobacter crescentus | 1 | 2010 | 1 | 0.090 |
Why?
|
| Atenolol | 3 | 2003 | 10 | 0.090 |
Why?
|
| Sigma Factor | 1 | 2010 | 6 | 0.090 |
Why?
|
| Pain Perception | 1 | 2010 | 17 | 0.090 |
Why?
|
| Thoracic Nerves | 3 | 1980 | 4 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2010 | 53 | 0.090 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 160 | 0.090 |
Why?
|
| Neurotoxins | 2 | 2008 | 7 | 0.090 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 1990 | 3 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2013 | 474 | 0.090 |
Why?
|
| Diaphragm | 3 | 1998 | 14 | 0.090 |
Why?
|
| Spinal Nerve Roots | 4 | 1999 | 12 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2007 | 32 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2018 | 604 | 0.080 |
Why?
|
| Periaqueductal Gray | 1 | 1989 | 5 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 22 | 0.080 |
Why?
|
| Ventricular Function | 2 | 2004 | 25 | 0.080 |
Why?
|
| Anxiety | 2 | 2001 | 140 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 144 | 0.080 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 11 | 0.080 |
Why?
|
| Dextran Sulfate | 2 | 2005 | 9 | 0.080 |
Why?
|
| Adaptation, Physiological | 2 | 2006 | 158 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2008 | 18 | 0.080 |
Why?
|
| Brain Mapping | 6 | 1992 | 199 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 453 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2013 | 624 | 0.080 |
Why?
|
| Cholesterol | 3 | 2008 | 182 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2013 | 263 | 0.080 |
Why?
|
| Gallbladder | 2 | 1986 | 8 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2020 | 163 | 0.080 |
Why?
|
| Chromones | 1 | 2008 | 11 | 0.080 |
Why?
|
| Butadienes | 1 | 2008 | 14 | 0.080 |
Why?
|
| Cardiac Pacing, Artificial | 4 | 2004 | 146 | 0.080 |
Why?
|
| Hydrochloric Acid | 1 | 2008 | 14 | 0.070 |
Why?
|
| Nitriles | 1 | 2008 | 32 | 0.070 |
Why?
|
| Morpholines | 1 | 2008 | 27 | 0.070 |
Why?
|
| Baroreflex | 1 | 2007 | 5 | 0.070 |
Why?
|
| TRPC Cation Channels | 1 | 2008 | 33 | 0.070 |
Why?
|
| Serotonin | 3 | 2003 | 16 | 0.070 |
Why?
|
| Adult | 4 | 2013 | 7382 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2004 | 213 | 0.070 |
Why?
|
| Irritants | 1 | 2007 | 7 | 0.070 |
Why?
|
| Drug Interactions | 2 | 2004 | 77 | 0.070 |
Why?
|
| Potassium Channel Blockers | 2 | 1998 | 10 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2008 | 58 | 0.070 |
Why?
|
| Sensation | 1 | 1987 | 11 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2007 | 31 | 0.070 |
Why?
|
| Middle Aged | 4 | 2013 | 6817 | 0.070 |
Why?
|
| Digestion | 1 | 2007 | 14 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2007 | 34 | 0.070 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2006 | 3 | 0.070 |
Why?
|
| Chemoreceptor Cells | 1 | 2006 | 10 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2008 | 80 | 0.070 |
Why?
|
| Sodium Channel Blockers | 2 | 2004 | 11 | 0.070 |
Why?
|
| Ghrelin | 2 | 2017 | 7 | 0.070 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2017 | 5 | 0.070 |
Why?
|
| Receptors, Adrenergic | 1 | 2006 | 10 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2006 | 31 | 0.070 |
Why?
|
| Mediastinum | 1 | 2006 | 3 | 0.070 |
Why?
|
| Bronchi | 1 | 2006 | 38 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 36 | 0.070 |
Why?
|
| Postprandial Period | 2 | 2017 | 41 | 0.070 |
Why?
|
| Hypothalamus | 1 | 1986 | 29 | 0.070 |
Why?
|
| Bradycardia | 1 | 2006 | 17 | 0.070 |
Why?
|
| Fasting | 2 | 2017 | 77 | 0.070 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 5 | 0.070 |
Why?
|
| Tachycardia | 1 | 2006 | 72 | 0.070 |
Why?
|
| Neurons, Efferent | 2 | 2004 | 2 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2003 | 117 | 0.070 |
Why?
|
| Haplorhini | 7 | 1984 | 15 | 0.070 |
Why?
|
| Cell Line | 2 | 2020 | 672 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2006 | 24 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 152 | 0.060 |
Why?
|
| Abdomen | 2 | 2000 | 41 | 0.060 |
Why?
|
| Cytokines | 2 | 2019 | 438 | 0.060 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2005 | 12 | 0.060 |
Why?
|
| Horseradish Peroxidase | 2 | 1998 | 7 | 0.060 |
Why?
|
| Young Adult | 1 | 2013 | 2581 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 118 | 0.060 |
Why?
|
| Gallbladder Diseases | 1 | 1984 | 3 | 0.060 |
Why?
|
| Sodium Channels | 1 | 2004 | 8 | 0.060 |
Why?
|
| Peripheral Nerves | 2 | 2014 | 4 | 0.060 |
Why?
|
| Sacrococcygeal Region | 2 | 2006 | 3 | 0.060 |
Why?
|
| Primates | 1 | 1984 | 22 | 0.060 |
Why?
|
| Heart Rate, Fetal | 1 | 2004 | 2 | 0.060 |
Why?
|
| Nicotinic Antagonists | 1 | 2004 | 3 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2004 | 28 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 244 | 0.060 |
Why?
|
| Intercostal Nerves | 1 | 2004 | 1 | 0.060 |
Why?
|
| Vagus Nerve Diseases | 1 | 2004 | 2 | 0.060 |
Why?
|
| Ear, External | 1 | 2003 | 11 | 0.060 |
Why?
|
| Stress, Physiological | 3 | 2013 | 90 | 0.060 |
Why?
|
| Shoulder | 1 | 2003 | 7 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2024 | 36 | 0.060 |
Why?
|
| Head | 1 | 2003 | 16 | 0.060 |
Why?
|
| Air | 1 | 2003 | 22 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2024 | 49 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2024 | 68 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2024 | 43 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 3 | 2003 | 34 | 0.050 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2003 | 1 | 0.050 |
Why?
|
| Parasympathomimetics | 1 | 2003 | 3 | 0.050 |
Why?
|
| Histamine | 1 | 2003 | 9 | 0.050 |
Why?
|
| Pirenzepine | 1 | 2003 | 8 | 0.050 |
Why?
|
| Oxytocics | 1 | 2003 | 5 | 0.050 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 140 | 0.050 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2012 | 6 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 36 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2003 | 41 | 0.050 |
Why?
|
| Adenosine | 1 | 2003 | 33 | 0.050 |
Why?
|
| Respiratory Muscles | 1 | 2002 | 2 | 0.050 |
Why?
|
| Water | 1 | 2003 | 131 | 0.050 |
Why?
|
| Veratridine | 1 | 2002 | 1 | 0.050 |
Why?
|
| Spasm | 1 | 2001 | 4 | 0.050 |
Why?
|
| Respiration Disorders | 1 | 2001 | 7 | 0.050 |
Why?
|
| Cardiac Volume | 1 | 2001 | 7 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2001 | 5 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2001 | 27 | 0.050 |
Why?
|
| Muscle Contraction | 4 | 2007 | 162 | 0.050 |
Why?
|
| Vasomotor System | 2 | 1989 | 8 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 346 | 0.050 |
Why?
|
| Macaca mulatta | 6 | 1981 | 47 | 0.050 |
Why?
|
| Colonic Diseases, Functional | 1 | 2001 | 11 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2001 | 100 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2020 | 24 | 0.050 |
Why?
|
| K562 Cells | 1 | 2020 | 20 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2013 | 152 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2020 | 18 | 0.050 |
Why?
|
| Risk Factors | 6 | 2007 | 2010 | 0.050 |
Why?
|
| Epigenomics | 1 | 2020 | 28 | 0.050 |
Why?
|
| Genome | 1 | 2020 | 52 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2013 | 560 | 0.040 |
Why?
|
| Restraint, Physical | 1 | 2020 | 12 | 0.040 |
Why?
|
| Random Allocation | 1 | 2000 | 148 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2000 | 68 | 0.040 |
Why?
|
| Respiration | 1 | 2000 | 45 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 221 | 0.040 |
Why?
|
| Nervous System | 1 | 2019 | 12 | 0.040 |
Why?
|
| Quality of Life | 1 | 2004 | 464 | 0.040 |
Why?
|
| Headache | 1 | 2000 | 30 | 0.040 |
Why?
|
| Genomics | 1 | 2020 | 116 | 0.040 |
Why?
|
| Loperamide | 1 | 2019 | 1 | 0.040 |
Why?
|
| Pancreatic Polypeptide | 1 | 2019 | 1 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 538 | 0.040 |
Why?
|
| Exercise | 1 | 2004 | 451 | 0.040 |
Why?
|
| Ventricular Premature Complexes | 1 | 1999 | 5 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2019 | 73 | 0.040 |
Why?
|
| Models, Biological | 2 | 2020 | 446 | 0.040 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 1999 | 11 | 0.040 |
Why?
|
| Cordotomy | 1 | 1999 | 1 | 0.040 |
Why?
|
| GABA Agonists | 1 | 1999 | 4 | 0.040 |
Why?
|
| Muscimol | 1 | 1999 | 8 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 144 | 0.040 |
Why?
|
| Rabbits | 2 | 2012 | 272 | 0.040 |
Why?
|
| Cell Count | 3 | 1997 | 84 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 1980 | 151 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2021 | 646 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 406 | 0.040 |
Why?
|
| Propanolamines | 1 | 1998 | 16 | 0.040 |
Why?
|
| Synapses | 1 | 1999 | 48 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2018 | 22 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 23 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 66 | 0.040 |
Why?
|
| Fingers | 1 | 1998 | 16 | 0.040 |
Why?
|
| Imidazoles | 1 | 1998 | 60 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 1998 | 88 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 59 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 578 | 0.040 |
Why?
|
| Peroxidase | 1 | 2017 | 37 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 186 | 0.040 |
Why?
|
| Propranolol | 4 | 2003 | 38 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2020 | 509 | 0.030 |
Why?
|
| Cell Size | 1 | 1996 | 22 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1997 | 151 | 0.030 |
Why?
|
| Counterpulsation | 1 | 1995 | 1 | 0.030 |
Why?
|
| Sotalol | 1 | 1995 | 9 | 0.030 |
Why?
|
| Atherectomy, Coronary | 1 | 1995 | 9 | 0.030 |
Why?
|
| Touch | 2 | 1994 | 12 | 0.030 |
Why?
|
| Peptide YY | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pericytes | 1 | 2014 | 17 | 0.030 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2014 | 2 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2014 | 23 | 0.030 |
Why?
|
| Ganglia, Sympathetic | 2 | 1993 | 8 | 0.030 |
Why?
|
| Microinjections | 2 | 2002 | 14 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2014 | 18 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1994 | 19 | 0.030 |
Why?
|
| Neuronavigation | 1 | 2014 | 9 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 21 | 0.030 |
Why?
|
| Wound Infection | 1 | 2014 | 13 | 0.030 |
Why?
|
| Optogenetics | 1 | 2014 | 6 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 12 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 50 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 17 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2014 | 37 | 0.030 |
Why?
|
| Hematoma | 1 | 2014 | 26 | 0.030 |
Why?
|
| Culture Media | 1 | 2014 | 97 | 0.030 |
Why?
|
| Analgesics | 1 | 2014 | 34 | 0.030 |
Why?
|
| Checklist | 1 | 2014 | 21 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 40 | 0.030 |
Why?
|
| Anesthesia | 1 | 1994 | 25 | 0.030 |
Why?
|
| Urination | 1 | 1994 | 13 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2014 | 35 | 0.030 |
Why?
|
| Tetrahydroisoquinolines | 1 | 1994 | 3 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 108 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 1994 | 6 | 0.030 |
Why?
|
| Potassium Chloride | 2 | 2007 | 10 | 0.030 |
Why?
|
| Motor Neurons | 2 | 2004 | 41 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 87 | 0.030 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1993 | 3 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1993 | 5 | 0.030 |
Why?
|
| Patient Selection | 1 | 2014 | 143 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1993 | 7 | 0.030 |
Why?
|
| Oscillometry | 1 | 2013 | 4 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 43 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2014 | 103 | 0.030 |
Why?
|
| Diabetic Neuropathies | 1 | 2013 | 14 | 0.030 |
Why?
|
| Neurosurgery | 1 | 2014 | 75 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2013 | 28 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2013 | 54 | 0.030 |
Why?
|
| Hyperemia | 1 | 2013 | 31 | 0.030 |
Why?
|
| Respiratory Center | 1 | 1992 | 1 | 0.030 |
Why?
|
| Proteolysis | 1 | 2013 | 55 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2014 | 178 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 106 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2013 | 75 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 357 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1992 | 4 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 1992 | 114 | 0.030 |
Why?
|
| Adrenergic Neurons | 1 | 2012 | 3 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2013 | 118 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 89 | 0.030 |
Why?
|
| Cholinergic Neurons | 1 | 2012 | 5 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 264 | 0.030 |
Why?
|
| Binding Sites | 1 | 2013 | 338 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 293 | 0.020 |
Why?
|
| Consciousness | 2 | 1988 | 6 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 573 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 133 | 0.020 |
Why?
|
| Telemedicine | 1 | 2014 | 135 | 0.020 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 1991 | 1 | 0.020 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1991 | 2 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 63 | 0.020 |
Why?
|
| Coronary Occlusion | 1 | 2012 | 39 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 386 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 631 | 0.020 |
Why?
|
| Parasympathetic Nervous System | 1 | 1991 | 17 | 0.020 |
Why?
|
| Ischium | 1 | 2010 | 1 | 0.020 |
Why?
|
| Man-Machine Systems | 1 | 2010 | 3 | 0.020 |
Why?
|
| Pressure Ulcer | 1 | 2010 | 5 | 0.020 |
Why?
|
| Lidocaine | 1 | 1990 | 27 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 2004 | 61 | 0.020 |
Why?
|
| Aged | 3 | 2009 | 5166 | 0.020 |
Why?
|
| RNA, Bacterial | 1 | 2010 | 65 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 110 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 205 | 0.020 |
Why?
|
| Kainic Acid | 2 | 1989 | 4 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 211 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 214 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 322 | 0.020 |
Why?
|
| Axonal Transport | 2 | 1986 | 3 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 91 | 0.020 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2008 | 4 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 441 | 0.020 |
Why?
|
| Mifepristone | 1 | 2008 | 4 | 0.020 |
Why?
|
| Hormone Antagonists | 1 | 2008 | 6 | 0.020 |
Why?
|
| Spironolactone | 1 | 2008 | 4 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 674 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 450 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 400 | 0.020 |
Why?
|
| Hemodynamics | 3 | 1995 | 220 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1036 | 0.020 |
Why?
|
| Ibotenic Acid | 1 | 2008 | 1 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 228 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2008 | 114 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 980 | 0.020 |
Why?
|
| Carbachol | 1 | 2007 | 18 | 0.020 |
Why?
|
| Enema | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2007 | 6 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2007 | 26 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 34 | 0.020 |
Why?
|
| Exercise Test | 1 | 1988 | 246 | 0.020 |
Why?
|
| Bronchoconstriction | 1 | 2006 | 1 | 0.020 |
Why?
|
| Ligation | 1 | 2007 | 39 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 38 | 0.020 |
Why?
|
| Joints | 1 | 1986 | 12 | 0.020 |
Why?
|
| Cystitis, Interstitial | 1 | 2006 | 17 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 110 | 0.020 |
Why?
|
| Tritium | 1 | 1986 | 17 | 0.020 |
Why?
|
| Autoradiography | 1 | 1986 | 28 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 747 | 0.020 |
Why?
|
| Research Design | 1 | 2007 | 174 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 472 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 186 | 0.020 |
Why?
|
| Amino Acids | 1 | 1986 | 80 | 0.020 |
Why?
|
| Stroke Volume | 1 | 1986 | 111 | 0.020 |
Why?
|
| Proteomics | 1 | 2007 | 177 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2005 | 209 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 12 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2004 | 10 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 30 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 2004 | 18 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 1984 | 22 | 0.010 |
Why?
|
| Decerebrate State | 1 | 2004 | 2 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 5 | 0.010 |
Why?
|
| Paralysis | 1 | 2004 | 9 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2004 | 34 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 1927 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2004 | 54 | 0.010 |
Why?
|
| Myocardium | 1 | 1984 | 171 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2003 | 2 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2003 | 23 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 100 | 0.010 |
Why?
|
| Tachyphylaxis | 1 | 1982 | 1 | 0.010 |
Why?
|
| Nerve Crush | 1 | 2002 | 3 | 0.010 |
Why?
|
| Brachial Plexus | 1 | 2002 | 6 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 50 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2004 | 127 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1982 | 21 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 203 | 0.010 |
Why?
|
| Tail | 1 | 1982 | 4 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 970 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 2001 | 20 | 0.010 |
Why?
|
| Hair | 1 | 1981 | 15 | 0.010 |
Why?
|
| Aging | 1 | 2009 | 945 | 0.010 |
Why?
|
| Testis | 1 | 1981 | 39 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2001 | 7 | 0.010 |
Why?
|
| Drug Implants | 1 | 2001 | 14 | 0.010 |
Why?
|
| Atropine | 2 | 1991 | 47 | 0.010 |
Why?
|
| Manometry | 1 | 2001 | 36 | 0.010 |
Why?
|
| Acetic Acid | 1 | 2001 | 28 | 0.010 |
Why?
|
| Reflex, Startle | 1 | 2000 | 8 | 0.010 |
Why?
|
| Rats, Inbred WKY | 1 | 2000 | 13 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2001 | 107 | 0.010 |
Why?
|
| Phenylephrine | 2 | 1992 | 13 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2000 | 30 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2000 | 16 | 0.010 |
Why?
|
| Cerebellum | 1 | 1980 | 40 | 0.010 |
Why?
|
| Succinylcholine | 1 | 1979 | 3 | 0.010 |
Why?
|
| Substance P | 1 | 1997 | 6 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 1997 | 22 | 0.010 |
Why?
|
| Glutamates | 1 | 1977 | 14 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1995 | 45 | 0.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1995 | 4 | 0.010 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 1975 | 1 | 0.010 |
Why?
|
| Axons | 1 | 1975 | 24 | 0.010 |
Why?
|
| Peroneal Nerve | 1 | 1975 | 3 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1975 | 11 | 0.010 |
Why?
|
| Prazosin | 1 | 1994 | 3 | 0.010 |
Why?
|
| Aminoquinolines | 1 | 1994 | 11 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1994 | 65 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1994 | 276 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1994 | 400 | 0.010 |
Why?
|
| Biomarkers | 1 | 1995 | 733 | 0.010 |
Why?
|
| Tocainide | 1 | 1990 | 1 | 0.010 |
Why?
|
| Reference Values | 1 | 1991 | 198 | 0.010 |
Why?
|
| Survival Rate | 1 | 1990 | 406 | 0.010 |
Why?
|
| Prognosis | 1 | 1990 | 759 | 0.000 |
Why?
|
| Rest | 1 | 1988 | 93 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1990 | 1216 | 0.000 |
Why?
|
| Autonomic Fibers, Postganglionic | 2 | 1978 | 2 | 0.000 |
Why?
|
| Neuromuscular Junction | 1 | 1985 | 21 | 0.000 |
Why?
|
| Potassium | 1 | 1985 | 41 | 0.000 |
Why?
|
| Leucine | 1 | 1984 | 18 | 0.000 |
Why?
|
| Proline | 1 | 1984 | 11 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1990 | 2433 | 0.000 |
Why?
|
| Clonidine | 1 | 1982 | 10 | 0.000 |
Why?
|
| Dominance, Cerebral | 1 | 1982 | 10 | 0.000 |
Why?
|
| Perineum | 1 | 1982 | 14 | 0.000 |
Why?
|
| Carotid Arteries | 1 | 1982 | 52 | 0.000 |
Why?
|
| Pelvis | 1 | 1981 | 37 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1976 | 94 | 0.000 |
Why?
|
| Thermoreceptors | 1 | 1975 | 1 | 0.000 |
Why?
|
| Pentobarbital | 1 | 1975 | 3 | 0.000 |
Why?
|
| Diencephalon | 1 | 1975 | 3 | 0.000 |
Why?
|
| Computers | 1 | 1975 | 29 | 0.000 |
Why?
|